Annual Drug Patent Expirations for EPIDUO
Epiduo is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in two NDAs. It is available from two suppliers. There are sixteen patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for EPIDUO.
This drug has sixty-eight patent family members in twenty-six countries.
The generic ingredient in EPIDUO is adapalene; benzoyl peroxide. Two suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
